Please Wait
Applying Filters...
menu
    • menu
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    HealthTech BioActives, leading globally in Flavonoids and Vitamin B12 Derivatives.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Menu

    Urbanol

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 1,209Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Assertio Shares SYMPAZAN Oral Film Patient Study Results
    Assertio Shares SYMPAZAN Oral Film Patient Study Results

    15 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/15/3150030/0/en/Assertio-Presents-First-Ever-Real-World-Study-Showing-Patient-Experience-with-SYMPAZAN-clobazam-Oral-Film-CIV.html

    GLOBENEWSWIRE
    15 Sep 2025
    Share Share
    Assertio Presents Sympazan Study Data at Neurology Meeting
    Assertio Presents Sympazan Study Data at Neurology Meeting

    10 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/10/3147667/0/en/Assertio-to-Present-New-Data-from-Real-World-Evidence-Study-of-SYMPAZAN-at-upcoming-150th-Annual-Meeting-of-the-American-Neurological-Association.html

    GLOBENEWSWIRE
    10 Sep 2025
    Share Share
    Enforcement Report - Week of January 22, 2025
    Enforcement Report - Week of January 22, 2025

    22 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-22-2025-57502.pdf

    FDA
    22 Jan 2025
    Share Share
    Enforcement Report - Week of January 15, 2025
    Enforcement Report - Week of January 15, 2025

    15 Jan 2025

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-15-2025-7287.pdf

    FDA
    15 Jan 2025
    Share Share
    Enforcement Report - Week of February 28, 2024
    Enforcement Report - Week of February 28, 2024

    28 Feb 2024

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2024-59068.pdf

    FDA
    28 Feb 2024
    Share Share
    Assertio Provides Educational Grant for New LGS Foundation Treatments Kits
    Assertio Provides Educational Grant for New LGS Foundation Treatments Kits

    24 Apr 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/04/24/2652743/0/en/Assertio-Provides-Educational-Grant-for-New-Lennox-Gastaut-Syndrome-LGS-Foundation-Treatments-Kits.html

    GLOBENEWSWIRE
    24 Apr 2023
    Share Share